Product Information
QC ACETAMINOPHEN PM GELCAP is a generic product labeled by Chain Drug Marketing Association, priced at $0.0439 per EA under NDC 83324007020. Its NADAC has been published 62 times since Jul 30, 2025.
Strength
500; 25 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324007020
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
6/26/2025
Pharmacological Classes
Price Statistics
The NADAC for QC ACETAMINOPHEN PM GELCAP has been published 62 times since Jul 30, 2025, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0439 per EA |
|---|---|
| All-time high | $0.0478 (Aug 13, 2025) |
| All-time low | $0.0439 (Sep 23, 2026) |
| 52-week high | $0.0470 |
| 52-week low | $0.0439 |
| Median price | $0.0456 |
| Average price | $0.0459 |
| Largest weekly change | +3.1% (Dec 17, 2025) |
| Weeks tracked | 62 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen, Diphenhydramine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ACETAMINOPHEN PM GELCAP?
The current National Average Drug Acquisition Cost (NADAC) for QC ACETAMINOPHEN PM GELCAP, manufactured by Chain Drug Marketing Association, is $0.0439 per EA (NDC 83324007020), effective Sep 30, 2026.
How has the price of QC ACETAMINOPHEN PM GELCAP changed over time?
Over the history we have for it, the NADAC for QC ACETAMINOPHEN PM GELCAP has declined 8.2%. It has been tracked across 62 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for QC ACETAMINOPHEN PM GELCAP?
Since Jul 30, 2025, the NADAC for QC ACETAMINOPHEN PM GELCAP has ranged from a low of $0.0439 (Sep 23, 2026) to a high of $0.0478 (Aug 13, 2025), with a median of $0.0456 per EA.
Are there cheaper alternatives to QC ACETAMINOPHEN PM GELCAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as QC ACETAMINOPHEN PM GELCAP in a comparable dosage form, but none are currently priced below it.
Who manufactures QC ACETAMINOPHEN PM GELCAP?
QC ACETAMINOPHEN PM GELCAP (NDC 83324007020) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.